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35 Scope: To identify reliable biomarkers of food intake (BFIs) of pulses. 
36 Methods and results: A randomized crossover postprandial intervention study was conducted on 
37 11 volunteers who consumed lentils, chickpeas and white beans. Urine and serum samples were 
38 collected at distinct postprandial time points up to 48 h, and analyzed by LC-HR-MS untargeted 
39 metabolomics. Hypaphorine, trigonelline, several small peptides and polyphenol-derived 
40 metabolites proved to be the most discriminating urinary metabolites. Two arginine-related 
41 compounds, dopamine sulfate and epicatechin metabolites, with their microbial derivatives, were 
42 identified only after intake of lentils, whereas protocatechuic acid was identified only after 
43 consumption of chickpeas. Urinary hydroxyjasmonic and hydroxydihydrojasmonic acids, as well 
44 as serum pipecolic acid and methylcysteine, were found after white bean consumption. Most of 
45 the metabolites identified in the postprandial study were replicated as discriminants in 24 h urine 
46 samples, demonstrating that in this case the use of a single, noninvasive sample was suitable for 
47 revealing the consumption of pulses. 
48 Conclusions: The results of the present untargeted metabolomics work revealed a broad list of 
49 metabolites that are candidates for use as biomarkers of pulse intake. Further studies are needed 
50 to validate these BFIs and to find the best combinations of them to boost their specificity.
51
52
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54 Pulses refer to the edible nonoil dried seeds of legumes, such as lentils, chickpeas, dry beans 
55 and dry peas. They present a unique nutritional value characterized by a high content of protein, 
56 fiber and a variety of phytochemicals, as well as by a low glycemic index. Consumption of pulses 
57 has been associated with beneficial effects on human health. In fact, regular pulse consumption 
58 has been associated with lower body weight [1], blood pressure [2] and LDL cholesterol [3], as well 
59 as with an improvement in markers of glycemic control [4]. In recent years the promotion of their 
60 consumption has been prioritized by a wide range of public and private stakeholders culminating 
61 in the declaration of the year 2016 as the International Year of Pulses by the General Assembly of 
62 the United Nations, which was coordinated by the Food and Agriculture Organization of the 
63 United Nations. 
64 To study in depth the effects of these foods and to gain more insight into the molecular 
65 mechanisms by which they act, a precise measurement of food intake is required. Here, 
66 biomarkers of food intake (BFIs) have emerged as a promising tool for correctly assessing food 
67 intake [5]. To date, only a limited number of foods have been associated with validated BFIs, but 
68 pulses are not among them, since only a few studies dealing with this topic have been recently 
69 published [6–11]. The first of them was focused on the quantification of kaempferol in urine after 
70 bean consumption [6]. However, this compound is present in a wide range of vegetables [12]. 
71 Results from another human study suggested serum pipecolic acid and S-methylcysteine as 
72 biomarkers of dry bean consumption [7]. Animal studies reported an increase in the urinary 
73 excretion of trigonelline, homoeridictyol chalcone and two peptides after a bean-based diet in 
74 dogs [8], and increased urinary excretions of different species of dipeptides, as well as arginine-
75 related metabolites in hypertensive rats fed with lentils [9]. More recently our research group 
76 published two human studies applying untargeted NMR experiments, one in an observational 
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77 framework [10] while the other was a postprandial controlled intervention study [11]. The first 
78 study showed that pulse consumers had higher urinary excretions of different metabolites related 
79 to choline, protein and energy metabolism [10], whereas the results of the second study suggested 
80 trigonelline, 3-methylhistidine, dimethylglycine, TMA, glutamine, choline, lysine and histidine 
81 as candidate biomarkers of pulse intake [11]. However, as the authors pointed out, these 
82 metabolites are not highly specific to pulse consumption.
83 In light of this scarcity of knowledge regarding biomarkers of pulse consumption, the aim of 
84 the present study was to assess the metabolic fingerprint of urine and serum associated with their 
85 intake in order to further identify reliable BFIs of the most commonly consumed types of pulses 
86 (i.e. lentils, chickpeas and dry beans) using an LC-MS untargeted metabolomics approach. This 
87 technique enables the detection of a wide range of metabolites even at low concentrations while 
88 biosamples selected for analysis usually carry a large amount of dietary information. This 
89 research was developed within the same context of the NMR study mentioned before [11]. In 
90 addition to analyzing the nutrikinetic profiles in urine and serum, in this study we aimed to go 
91 one step further and develop a complementary experiment with pooled urinary samples. This was 
92 focused on a comparision of the data provided by the nutrikinetic profile with the 6 h and 24 h 
93 pooled urine samples to check the overlapping information. The aforementioned experiment was 
94 carried out in order (1) to get an overview of the postprandrial impact of the evaluated foods 
95 without the interference of any additional intake (6 h pools), and (2) to evaluate the information 
96 provided by a simpler, less expensive and more easily available type of sample such as the 24 h 
97 urine pool.
98
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99 2. MATERIALS AND METHODS
100 2.1. Study design 
101 The design of this study (Figure 1) has been defined within the frame of the European JPI-
102 funded project “Food Biomarker Alliance” (FoodBAll) [13]. In fact, this is one of the seven 
103 standardized postprandial intervention studies designed to discover new potential food intake 
104 biomarkers for a broad range of common foods. Our study was focused on different types of the 
105 most commonly consumed kinds of pulses, i.e. lentils, chickpeas and white beans, using white 
106 pasta as the control food. The study was registered at the ISRCTN registry with the code 
107 ISRCTN17200423. Details of this randomized, controlled, crossover study have been reported 
108 previously [11] and are listed in the Supporting Information. The clinical intervention was 
109 approved by the Bioethical Committee of the University of Barcelona (ref: IRB00003099) and 
110 followed Helsinki Declaration guidelines.
111 A total of 84 subjects expressed their interest in participating in this study, of whom 31 were 
112 screened. Twenty-six of them fulfilled the inclusion criteria and 14 were enrolled since they were 
113 the ones that finally fully agreed to participate in the study, with 11 (four men and seven women) 
114 completing the study in a crossover design with lentils, chickpeas and pasta (Figure S1). A 
115 subgroup of eight participants underwent the fourth intervention with white beans, which was 
116 scheduled later. The subjects were on average 28 ± 6 years old (range: 19‒37) and had a BMI of 
117 23.8 ± 3.6 kg/m2 (range: 18.6‒28.9).
118
119 2.2. Analysis of food samples 
120 Test foods were freeze-dried in the study center, shipped to the analytical lab on dry ice and 
121 stored at -80 °C before further peparation. Twenty mg of each sample were extracted twice with 
122 methanol/tert-butyl methyl ether first and methanol/water afterwards. Aliquots of the 
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123 supernatants were then evaporated in a SpeedVac and subsequently derivatized (methoximated 
124 and trimethylsilylated). Untargeted analyses were performed by LC-MS (results previously 
125 published by Llorach et al.[14]) and also using a comprehensive two-dimensional gas 
126 chromatography mass spectrometry (GC×GC-MS) system described elsewhere [15]. Data 
127 processing was done using the SquareDance workflow developed for GC×GC-qMS data sets [16] . 
128 Further details of sample preparation and the analytical procedure are provided in the Supporting 
129 Information. Automated compound annotation was performed using an in-house spectral library 
130 with fatty acid methyl esters-based retention indices. Finally, the annotation was manually 
131 verified by matching against the National Institute of Standards and Technology v14 library, the 
132 Fiehn library and the Golm Metabolome Database. The compounds identified in the four food 
133 products through the analyses with comprehensive two-dimensional gas chromatography mass 
134 spectrometry are listed in Table S2.
135
136 2.3. Untargeted metabolomics experiments on biological samples
137 Untargeted metabolomics analyses were performed in accordance with previously validated 
138 methodologies [17]. Briefly, urine samples were diluted with a series of internal and external 
139 standards in pure methanol and in Milli-Q water, whereas serum samples were prepared using 
140 Ostro plates. Afterwards, all samples were subjected to high-throughput metabolomics analysis 
141 using a reversed-phase liquid chromatography coupled to a high-resolution Orbitrap mass 
142 spectrometer. Later, acquired data were processed using the XCMS package in the R platform. A 
143 detailed description of these procedures, together with an exhaustive explanation about statistical 
144 analysis and metabolite identification, is given in Supporting Information (section “Untargeted 
145 metabolomics experiments on biological samples”).
146
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148 3.1. Identification of metabolites associated with legume consumption in the nutrikinetic 
149 study
150 Data adquired in this study showed good analytical performance. In-depth information about 
151 the quality of acquired data, as well as verification of data processing, is provided in the section 
152 “Data acquisition quality” in Supporting Information. After the processing of the raw MS data, 
153 further filtration steps were applied to the obtained data sets in order to reduce the amount of 
154 noisy and/or irrelevant features. The number of features in both the original and filtered data sets 
155 can be found in Supporting Information (“Data filtering” section). Finally, before proceeding 
156 with the feature selection, principal component analysis (PCA) was applied on each data set to 
157 explore trends in the data. A complete description of these results and their interpretation is 
158 provided in the section “Unsupervised multivariate analysis” in Supporting Information.
159 Among all the features retained after data filtering, 320 met the first selection requirement, 
160 based on their nutrikinetic curve behavior (see Supporting Information for futher details). Of 
161 these, 265 were found to be statistically significant (adjusted p-value < 0.05 of AUCs), 151 of 
162 which were assigned to one of the 54 identified metabolites (Table 1), whereas the rest remained 
163 unknown. Out of the 54 identified metabolites, 12 were identified at level I, 29 at level II and 13 
164 at level III. Identified compounds were categorized into several groups taking into consideration 
165 information on the chemical class of their precursors (metabolites) or their common pathways of 
166 origin (Figure S5): small peptides, flavan-3-ol-derived metabolites, other polyphenol-derived 
167 metabolites, fatty acids, other food-derived metabolites and endogenous metabolites. A detailed 
168 description of the identification of discriminant metabolites is provided in the section 
169 “Identification of discriminating metabolites” in the Supporting Information, and information 
170 regarding their fragmentation spectra is given in Table S5. The responses of a selected group of 
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171 characteristic metabolites are depicted in Figure 2, while Figure S6 includes the kinetic curves of 
172 all identified metabolites. All plots were constructed with the MS response (peak area) of the 
173 most intensive feature of each metabolite. 
174
175 3.2. Experiment on pooled samples
176 In order to compare the data provided by nutrikinetic profiles and a simpler type of sample 
177 such as 24 h urine, an additional experiment was performed. This was done with the aim of 
178 checking the overlapping information between these types of samples. Additionally, 6 h urine 
179 pools were also analyzed since during the first 6 hours volunteers only ingested the test meal (i.e. 
180 this pool included samples collected 1h, 2h, 4h and 6h after consuming the study food, Figure 1). 
181 In both cases, most of the identified urinary metabolites in the nutrikinetic experiments were also 
182 observed as being discriminant in both types of pooled samples (Table S6 and Figure S7). This 
183 demonstrates that in this case using a simpler type of sample (in that it is not required for the 
184 study volunteer to collect the samples in different containers) is also useful for observing the 
185 BFIs of pulse consumption. This has important connotations since 24 h urinary samples are 
186 usually collected in long intervention and epidemiological studies (although unfortunately some 
187 of them only have available spot urine instead of 24 h urine samples). Furthermore, the HCA 
188 (Figure 3) demonstrated that, although not all statistically significant features were annotated, the 




193 In this work, several metabolites were found to be associated with the intake of some of the 
194 most widely consumed types of pulses. They were identified using liquid chromatography 
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195 coupled to high-resolution mass spectrometry. Most of these metabolites are candidates as BFIs 
196 for this food group since they showed increased urinary and/or serum concentrations after the 
197 consumption of at least one type of pulse, while the values observed after the consumption of the 
198 control food (pasta) were negligible. It was difficult to find biomarkers exclusively for one type 
199 of pulse, as most of them were common to at least two or three pulse types. The exceptions were 
200 flavan-3-ol-derived metabolites (M27‒M31), two arginine-related compounds (M25 and M26) 
201 and dopamine sulfate (M43), which appeared to be specific for lentil intake in urine samples, 
202 whereas protocatechuic acid glucoside (M37) and ascorbic acid (M42) were elevated after the 
203 consumption of chickpeas. Hydrojasmonic (M39) and two hydroxydihydrojasmonic (M40 and 
204 M41) acids were characteristic of white bean intake. In serum samples, methylcysteine (M45) 
205 and pipecolic acid (M46) also resulted in particular from white bean consumption, and in both 
206 types of biosamples hypaphorine (M44) was discriminant for chickpeas and lentils. Two of the 
207 identified BFIs (i.e. methylcysteine and pipecolic acid) were detected as such in the test food to 
208 which they were assigned as markers (Table S2). This observation indicates that they were most 
209 likely nonmetabolized or not fully metabolized, suggesting that they would not be subject to 
210 substantial interindividual differences.
211
212 4.1. BFI for lentils
213 The results for flavan-3-ol-derived metabolites are consistent with the analyses of test foods, 
214 which showed that catechins were particular to lentils (Table S2). They were observed only in 
215 urine and their presence is due to the metabolism of catechins and proanthocyanidins by host and 
216 by intestinal microbiota. The urine integrated intensity-time curves clearly show two distinct 
217 nutrikinetic patterns, as already reported in another independent postprandrial dietary intervention 
218 [17]. On the one hand, (epi)catechin sulfate (M27) reached its maximum urinary levels within the 
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219 first 2‒4 h post-consumption followed by a rapid decrease within the next few hours. This 
220 behavior suggests that this compound is probably absorbed in the upper part of the 
221 gastrointestinal tract with little or no contribution from the microbiota. On the other hand, the 
222 four valerolactone-derived metabolites (M28‒M31) were characterized by a delayed appearance 
223 in urine. Their levels started to increase 4 h after consumption of lentils, reaching the maximum 
224 levels after 12 h, still being significantly higher after 24 h and reaching the baseline values within 
225 48 h. This performance suggests a prolonged metabolism throughout the large intestine with the 
226 involvement of the microbiota. These profiles are in good agreement with previous studies 
227 reporting the presence of (epi)catechin and valerolactone conjugates in urine [17]. This suggests 
228 that the former may only be useful as a BFI when 24 h urine is available, whereas the others 
229 could be more useful as BFIs when only spot urines are accessible. However, increases in urinary 
230 excretions after the intake of other catechin- and proanthocyanidin-rich foods such as tea, cocoa 
231 and grape products have also been observed in previous studies [18], thereby limiting their 
232 specificity as candidate BFIs of lentils. Additionally, hydroxy- and oxoarginine (M25 and M26) 
233 urinary levels also increased with the intake of lentils. Maximum excretions of these compounds 
234 were observed 4 and 6 hours, respectively, after intake of lentils, although differences were 
235 observed from the first few hours until 48 h post-consumption (Table 1). Hydroxyarginine is a 
236 free nonprotein amino acid particular to lentils [9], and oxoarginine is a metabolite of the arginine 
237 pathway recently associated with lentil consumption [9]. Therefore, they are interesting indicators 
238 of lentil intake. Additionally, it has been suggested that they could contribute to the blood 
239 pressure-lowering effects associated with the consumption of lentils through an increase in the 
240 production of nitric oxide [9]. Due to the well-known degradation of the guanidino group during 
241 trimethylsilylation prior to GC×GC-MS analysis, the presence (or abundance) of arginine and 
242 related compounds in the test foods could not be determined [19]. An increased urinary excretion 
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243 of dopamine sulfate (M43, the predominant form of dopamine in the circulation) was also 
244 particularly noticeable after the consumption of lentils. It has already been reported that it is 
245 largely affected by meal consumption, coming from the intake of dopamine, dopamine sulfate or 
246 L-dihydroxyphenylalanine (DOPA), the conversion of dietary tyramine to dopamine, the action 
247 of tyrosinase to produce L-DOPA in the gastrointestinal lumen, or an increased release and 
248 metabolism of endogenous dopamine in gastrointestinal lining cells [20]. Very recently, dopamine 
249 sulfate was found to be among the BFIs best predicting the intake of banana [21].
250
251 4.2. BFI for chickpeas
252 Ascorbic acid (M42) appeared as a discriminant compound for chickpea consumption during 
253 the period 4 h to 6 h post-intake. In line with that, its oxidation product, dehydroascorbic acid, 
254 was only detected in high amounts in chickpeas (Table S2). However, ascorbic acid cannot be 
255 considered a compound from chickpeas per se, since it is employed as a food additive. 
256 Furthermore, since it is widely used in the food industry as a stabilizing agent, it lacks the 
257 specificity to be used as a BFI and was not further investigated.
258
259 4.3. BFI for white beans
260 Methylcysteine (M45) and pipecolic acid (M46) appeared in serum samples particularly after 
261 white bean intake. Their levels were already significantly increased 1 h post-consumption and 
262 remained as such until the period 24 h‒48 h (Table 1, Figure S7a). In accordance with this 
263 observation, the serum levels of pipecolic acid and methylcysteine have already been proposed as 
264 potential biomarkers of dry bean consumption [7]. They are common nonprotein nitrogen 
265 components of the Phaseolus vulgaris species [22]. Specifically, whereas methylcysteine is not 
266 influenced by microbial metabolism, pipecolic acid has been reported to be a product of 
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267 microbial metabolism derived from lysine and has been described as a precursor of microbial 
268 compounds with anti-inflammatory, antitumor and antibiotic properties [7]. On the other hand, 
269 three jasmonic derivatives (M39‒M41) appeared to be particular to white bean intake. They are 
270 lipid-derived phytohormones generated in plants as a response to stress and their presence has 
271 been described in different varieties and cultivars of Vicia faba beans [23].
272
273 4.4. BFI for legumes
274 As legumes are an important food source of proteins, amino acid-derived metabolites could be 
275 indicators of their consumption. Indeed, we observed higher serum and/or urinary levels of 
276 several species of di- and tripeptides (M01‒M17). When differences among the different types of 
277 legumes were observed, in most cases chickpeas were among the types that resulted in the 
278 highest concentrations. This could have been related to the fact that chickpeas could have a 
279 higher amount of protein in their composition, but this did not turn out to be the case when we 
280 consulted the nutritional composition of the foods used [11]. These compounds may indicate that 
281 they are directly excreted in urine after pulse intake, and/or may represent proteolytic breakdown 
282 products of larger proteins present in these food sources. Most of the peptides were aspartyl-
283 containing compounds. Interestingly, in another study developed within the FoodBAll project but 
284 focused on meat biomarkers, a series of small peptides were also identified as BFIs. However, in 
285 that case these were hydroxyproline-containing di- and tripeptides [24] and none of them were in 
286 line with the present study where a completely different protein-based food was consumed.
287 Another interesting discriminant compound was hypaphorine (M44), which is also referred to 
288 as tryptophan betaine or lenticin. This last nomenclature was assigned since it is found in lentils 
289 [25,26], althougth it has also been reported in chickpeas [27]. It is an indole alkaloid composed of 
290 tryptophan and three methyls. In the present study, it has been observed as being discriminant for 
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291 the consumption of chickpeas and lentils both in serum and urine biofluids. In serum it has been 
292 observed as discriminant in the first hour after consumption, peaking 4‒6 h after consumption 
293 and resulting in a prolonged disappearance in both biofluids, indicating a slow excretion or 
294 metabolism. However, the complete clearance of its metabolism could not be estimated since this 
295 metabolite was still detected during the 24‒48 h period, when the last sample was collected. It 
296 has been correlated with nut intake in different cross-sectional studies [28–31], and it has also been 
297 associated with the Mediterranean diet [32] and the Dietary Approaches to Stop Hypertension 
298 (DASH) [33] dietary patterns. Additionally, a study focused on peanut consumption also reported 
299 its presence in the breast milk of lactating women [34]. Curiously, it has been positively associated 
300 with homocysteine levels after a Mediterranean-based dietary treatment in subjects with 
301 metabolic syndrome features [32]. Although it has been shown to be a compound with 
302 neurological and glucose-lowering effects in rodents, its potential functional role in humans 
303 remains to be addressed.
304 In parallel and in agreement with the results observed in our NMR experiments [11], urinary 
305 levels of trigonelline (M47) were also increased after intake of the three different types of pulses. 
306 In this case, urinary trigonelline achieved higher levels after the intake of white beans followed 
307 by chickpeas and lentils, reflecting the different amounts observed in their composition [11] and, 
308 therefore, suggesting a possible dose-response connection. Interestingly, this was also described 
309 after bean consumption in the two independent untargeted studies previously published [7,8]. 
310 However, this alkaloid has also been proposed as a BFI of coffee intake [35]. Therefore, this lack 
311 of specificity could limit its use as a single BFI, but we hypothesize that it could be considered 
312 within a multi-metabolite biomarker panel together with some of the other discriminating 
313 metabolites also observed in this study [18]. For example, combined with flavan-3-ol-derived 
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314 metabolites, arginine-related compounds and hypaphorine increase the specificity for monitoring 
315 lentil consumption. 
316 Other metabolites whose amounts were increased in urine after pulse intake were tentatively 
317 identified as phloroglucinol glucuronide (M32) and phloroglucinol sulfate (M33). Both are 
318 metabolites containing benzoyl groups, probably generated by microbial degradation of 
319 polyphenols contained in pulses, and therefore reflecting polyphenol metabolite cleavage 
320 products of gut microbiota action.
321
322 4.5. Endogenous metabolites
323 Major increases in glucuronidated forms of dicarboxylic fatty acids (i.e. dodecanedioic acid 
324 glucuronide, M51, and tretradecanedioic acid glucuronide, M53) and hydroxy fatty acids (i.e. 
325 dihydroxydecanoic acid glucuronide, M50, and hydroxydodecadienoic acid glucuronide, M52) 
326 were observed after pasta intake (used as control food) when compared with the consumption of 
327 the other types of pulses. Given the type of metabolites (glucuronidated medium-chain fatty 
328 acids), these metabolites probably reflect a differential endogenous response rather than being a 
329 metabolite from an exogenous food compound (also bearing in mind that pasta was not the food 
330 with the highest fat content [11]). Therefore, this could indicate a different response related to lipid 
331 metabolism. For example, in the case of dicarboxylic fatty acids, they probably reflect a shift 
332 from a reduced β-oxidation toward an enhanced ω-oxidation of fatty acids since dicarboxylic 
333 fatty acids are enhanced when there is a deficiency in fatty acid oxidation or when β-oxidation is 
334 overwhelmed [36]. Additionally, dihydroxydecanoic acid is an intermediate from the ω-oxidation 
335 of hydroxydecanoic acid to hydroxydecanedioic acid [37], and 4-hydroxydodecadienoic acid has 
336 also been previously detected in human urine and measured in higher amounts in situations 
337 characterized by the presence of oxidative stress such as that due to aging and diabetes [38]. Given 
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338 that insulin resistance is mediated by a dysregulation of fatty acid metabolism [39] and that pulse 
339 consumption has been associated with both better glycemic control [4] and healthier blood lipid 
340 levels [3], the differential urinary levels of these metabolites could be related to an alteration in the 
341 corresponding pathways manifested early postprandially that could mediate these beneficial 
342 effects already observed in the aforementioned clinical outputs. However, given the design of the 
343 current study, this is only a hypothesis of the underlying mechanisms, which should be verified in 
344 further studies designed specifically for this purpose.
345
346 4.6. Strengths and weaknesses
347 Most of the BFIs identified in urinary samples from the kinetic study were replicated as 
348 discriminant metabolites in 24 h pooled urine. The collection of this type of sample is much 
349 simpler than the methodology that has to be used for performing a nutrikinetic study. 
350 Additionally, in several epidemiological and intervention studies this type of sample is the one 
351 collected by the researchers. Therefore, our observation has important connotations for the future, 
352 since it demonstrates that with this type of sample we can reach the same conclusions. 
353 Additionally, further analyses of 24 h urine samples available in biobanks from previous studies 
354 with legumes will be able to be carried out in order to see which of these candidate BFIs for 
355 legumes are replicated in independent studies. 
356 Given that in the already available scientific bibliography none of the identified metabolites 
357 were highly specific, further research focused on their combination is required in order to 
358 evaluate their robustness and usefulness as candidate BFIs of these foods.
359 The crossover design of the present study allowed comparisons between the different meals on 
360 a within-participant basis. This allowed a better evaluation of the treatment effect since each 
361 participant served as its own control [40]. However, it was not the case with white beans, which 
Page 18 of 34
Wiley-VCH































































362 were administered in the last phase for all volunteers. Further, an additional untargeted analysis 
363 of the study foods helped us to find out whether the detected marker candidates were original 
364 constituents of the test foods or resulted from host or microbial metabolism. 
365 The study also has some additional weaknesses. Firstly, a full-confidence identification level 
366 could not be reached for most of the differential metabolites as the corresponding chemical 
367 standards were commercially unavailable. However, identifications at level II and III have also 
368 provided interesting information that has allowed us to infer a biological interpretation of the 
369 observed results of the present study. On the other hand, the highly controlled environment in 
370 which the participants were involved throughout the study together with the high quantity of food 
371 provided would have favored the observation of significant candidate BFIs. Therefore, some of 
372 the candidate BFIs deciphered in the current study could not be replicated in other studies with 
373 lower amounts of ingested food and/or where the background diet is not as controlled as in our 
374 case [40]. Therefore, further studies are needed to validate the results deciphered by the present 
375 analyses. Lastly, in this case, pasta was chosen as a control food since it is a low-polyphenol food 
376 product, although other foods could also have been chosen instead of it.
377
378 4.7. Concluding remarks
379 In conclusion, the results of the present untargeted metabolomics work revealed a long list of 
380 metabolites that are candidates to be used as biomarkers of pulse intake. Flavan-3-ol-derived 
381 metabolites and arginine-related compounds were found to be specific for lentils, whereas 
382 protocatechuic acid glucoside was particular to chickpeas; methylcysteine and pipecolic, 
383 hydroxyjasmonic and hydroxydihydrojasmoinic acids to white beans; and hypaphorine to 
384 chickpeas and lentils. On the other hand, a wide range of peptides, trigonelline and some 
385 polyphenol-derived metabolites appeared to be more generic indicators of pulse consumption. 
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386 Most of the BFIs identified in urinary samples were replicated as discriminant metabolites in 24 h 
387 pooled urine, demonstrating that with 24 h urine pools we can reach almost the same conclusions. 
388 The next step would be to develop and apply a quantitative method for the compounds identified 
389 in this untargeted metabolomics analysis. Next, biological validation will be required to test these 
390 candidate biomarkers in other populations with more individuals and under different 
391 experimental conditions and even under free-living conditions.
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505 Figure 1. Schematic representation of the design of the randomized, controlled, crossover 
506 study. This scheme was repeated in each treatment session. The top panel (above the dashed line) 
507 refers to the days that each of the interventions lasted, while the one below includes the 
508 information from the samples collected on the day of the intervention. Participants were assigned 
509 randomly to the test food in a crossover design. Urine samples were collected before the 
510 ingestion of the test product and during the indicated time intervals, whereas blood samples were 
511 also collected before the administration of the assigned meal and at the specified time points. 
512 After a one-week washout period, volunteers followed a two-day restricted diet before the 
513 intervention day. Standardized meals were provided to the volunteers from the dinner of the day 
514 before the intervention day, as well as from 6 h up to 48 h after the administration of the test 
515 food. 
516
517 Figure 2. Selected metabolite kinetic curves in urine and serum samples. X axis: time point; 
518 Y axis: peak intensity (MS response). Lines represent medians and bars IQR range. 
519 Abbreviations: C: control; B: white beans; L: lentils; P: chickpeas.
520
521 Figure 3. Heatmaps of identified metabolites after intake of lentils (L), chickpeas (P), beans 
522 (B) or control (C) in 6 h pools (A) and 24 h pools (B). Blue and orange cells correspond to low- 
523 and high-metabolite levels, respectively. Columns are samples, and rows are metabolites colored 
524 by treatment and class of compound, respectively.
525
Page 27 of 34
Wiley-VCH






























































Table 1. Identified metabolites that were significantly different in the nutrikinetics experiment after intake of lentils, chickpeas, white 
beans or control. 
M Metabolite Formula (m/z) RT Annotations LI (ref) Behavior
Fluid: 
time p-adjusted
M01 Asp-Ala C7H12N2O5 
(204.07461)
0.92 205.0819 [M+H]+ 2 
(MyCompoundID)
(L & P & B) > C U: 02h-
12h
4.47x10-5
M02 Asp-Gly / Gly-Asp C6H10N2O5 
(190.05896)
0.90 191.0662 [M+H]+ 1 (std) (L & P & B) > C U: 04h-
24h
7.97x10-5





U: 247.1289 [M+H]+; 248.1321 13C[M+H]+; 245.1145 [M-H]-; 
343.0913 [M-H+C2H3O2K]-; 227.1039 [M-H-H2O]- 
S: 247.1287 [M+H]+; 245.1142 [M-H]-






M04 Asp-Met C9H16N2O5S 
(264.07798)
1.43 265.0853 [M+H]+ 2 (std) P > (L & B & C) U: 02h-
12h
7.60x10-4
M05 Asp-Phe C13H16N2O5 
(280.10591)
3.77 281.1132 [M+H]+; 282.1165 13C[M+H]+; 279.0987 [M-H]- 2 (std) (L & P & B) > C U: 02h-
06h
1.12x10-5
M06 Asp-Ser / Ser-Asp C7H12N2O6 
(220.06952)
0.91 221.0769 [M+H]+ 3 (L & P & B) > C U: 04h-
12h
5.15x10-5





U: 297.1082 [M+H]+; 279.0976 [M+H-H2O]+ 
S: 297.1081 [M+H]+











U: 233.1132 [M+H]+ 
S: 233.1131 [M+H]+










5.46 360.2127 [M+H]+ 2 
(MyCompoundID)
(L & P) > B > C S: 02h-06h 9.81x10-6
M10 Asp-(i)Leu-Pro / (i)Leu-Asp-Pro C15H25N3O6 
(343.17432)
4.38 344.1818 [M+H]+ 3 P > L > (B & C) U: 06h-
12h
9.55x10-6
M11 Asp-Ala-(i)Leu / Ala-Asp-(i)Leu C13H23N3O6 
(317.15869)
3.64 318.1660 [M+H]+ 2 
(MyCompoundID)
P > (L & B & C) U: 04h-
12h
5.52x10-5
M12 Asp-Asn-Val / Asn-Asp-Val C13H22N4O7 
(346.14883)
1.31 347.1563 [M+H]+ 1 (std) (L & P) > B > C U: 02h-
12h
1.03x10-5





U: 304.1504 [M+H]+; 302.1359 [M-H]- 
S: 304.1503 [M+H]+






M14 Asp-Gly-Tyr / Gly-Asp-Tyr C15H19N3O7 
(353.12230)
1.86 354.1297 [M+H]+ 3 P > L > (B & C) U: 02h-
12h
1.85x10-5
M15 Asp-Gly-Val C11H19N3O6 
(289.12737)





M16 Asp-Thr-Pro / Thr-Asp-Pro C13H21N3O7 
(331.13793)
1.23 332.1453 [M+H]+ 3 P > L > (B & C) U: 04h-
24h
8.52x10-6
Page 28 of 34
Wiley-VCH






























































M17 Pro-HPro-Gly / HPro-Pro-Gly C12H19N3O5 
(285.13245)
3.74 286.1398 [M+H]+ 2 (Metlin) (L & P & B) > C U: 04h-
06h
1.71x10-2
M18 Cyclo((i)Leu-Phe) C15H20N2O2 
(260.15246)
6.75 261.1596 [M+H]+ 2 (Yamamoto 
2016 / MetFrag)
P > (L & B & C) S: 01h-06h 4.47x10-5
M19 Cyclo(His-Pro) C11H14N4O2 
(234.11166)
1.17 235.1191 [M+H]+ 2 (Yamamoto 
2016 / MetFrag)
(L & P) > B > C U: 01h-
04h
3.60x10-3
M20 (i)Leucine derivative (I) C10H18N2O5 
(246.12156)
3.64 247.1288 [M+H]+ 3 (L & P) > B > C S: 02h-06h 2.70x10-5





U: 289.1394 [M+H]+ 
S: 289.1392 [M+H]+






M22 Glycine derivative C9H17N3O4 
(231.12191)





M23 Phenylalanine derivative C21H25N3O5 
(399.17940)










U: 229.1183 [M+H]+ 
S: 229.1181 [M+H]+






M25 Hydroxyarginine C6H14N4O3 
(190.10658)
0.80 191.1139 [M+H]+ 2 (MetFrag) L > (P & B & C) U: 01h-
48h
6.28x10-5
M26 Oxoarginine C6H11N3O3 
(173.08003)
0.93 174.0873 [M+H]+ 2 (MetFrag) L > (P & B & C) U: 02h-
48h
1.61x10-4
M27 (Epi)catechin sulfate C15H14O9S 
(370.03584)
4.33 369.0287 [M-H]- 2 (van der Hoof 
2012)







4.23 305.0337 [M-H]- 2 (van der Hoof 
2012)







4.70 306.0643 [M+NH4]+; 287.0232 [M-H]-; 288.0265 13C[M-H]-; 
207.0664 [M-H-sulf]-
2 (van der Hoof 
2012)







4.58 385.1129 [M+H]+; 402.1395 [M+NH4]+; 209.0808 [M+H-gluc]+ 2 (van der Hoof 
2012)








4.76 416.1551 [M+NH4]+; 223.0964 [M+H-gluc]+; 397.1141 [M-H]- 2 (van der Hoof 
2012)
L > (P & B & C) U: 04h-
48h
8.09x10-6





U: 303.0711 [M+H]+; 304.0745 13C[M+H]+; 325.0531 [M+Na]+; 
341.027 [M+K]+; 468.1498 [+]; 301.0566 [M-H]-; 302.0597 
13C[M-H]-; 399.0336 [M-H+C2H3O2K]- 
S: 303.0710 [M+H]+











U: 206.9954 [M+H]+; 224.0228 [M+NH4]+; 244.9517 [M+K]+; 
127.0388 [M+H-sulf]+; 204.9814 [M-H]-; 205.9847 13C[M-H]-; 
206.9772 213C[M-H]-; 302.9583 [M-H+C2H3O2K]-; 125.0248 
[M-H-sulf]- 
S: 204.9814 [M-H]-






M34 2-Hydroxyhippuric acid C9H9NO4 
(195.05315)
5.28 196.0604 [M+H]+; 241.1048 [M+C2H8N]+; 239.0925 
[M+C2H8N]-
1 (std) B > (L & P & C) U: 01h-
06h
8.72x10-3
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M35 Aminosalicyluric acid C9H10N2O4 
(210.06405)
1.78 211.0713 [M+H]+; 209.0569 [M-H]- 3 (in silico) (L & P & B) > C U: 02h-
24h
6.37x10-6
M36 Muconic acid C6H6O4 
(142.02660)
1.64 141.0197 [M-H]- 2 (mzCloud) (L & P & B) > C U: 01h-
24h
5.52x10-5
M37 Protocatechuic acid glucoside C13H16O9 
(316.07942)
2.62 315.0722 [M-H]-; 413.0493 [M-H+C2H3O2K]- 2 (Cuparencu 
2016 / mzCloud)
P > L > (B & C) U: 02h-
04h
6.37x10-6
M38 Vanillic acid sulfate C8H8O7S 
(247.99906)
2.91 246.9920 [M-H]- 2 (mzCloud) L > (P & B & C) U: 04h-
12h
7.49x10-4
M39 Hydroxyjasmonic acid C12H18O4 
(226.12049)
5.18 227.1278 [M+H]+; 225.1134 [M-H]- 2 (Valente 2018) B > (L & P & C) U: 01h-
24h
6.96x10-4




4.81 229.1434 [M+H]+; 211.1328 [M+H-H2O]+; 193.1223 [M+H-
2(H2O)]+; 227.1290 [M-H]-
3 (in silico) B > (L & P & C) U: 01h-
12h
3.98x10-4




5.37 211.1328 [M+H-H2O]+; 227.1290 [M-H]- 3 (in silico) B > (L & P & C) U: 01h-
48h
8.99x10-4
M42 Ascorbic acid C6H8O6 
(176.03208)
0.95 177.0393 [M+H]+; 175.0251 [M-H]-; 115.0041 [M-H-C2H4O2]- 1 (std) P > (L & B & C) U: 04h-
06h
1.23x10-3
M43 Dopamine sulfate C8H11NO5S 
(233.03578)
1.31 234.0430 [M+H]+; 232.0287 [M-H]- 2 (std) L > (P & B & C) U: 01h-
12h
1.20x10-4





U: 247.1441 [M+H]+; 188.0706 [M+H-(CH3)3N]+ 
S: 247.1440 [M+H]+; 248.1473 13C[M+H]+; 188.0704 [M+H-
(CH3)3N]+; 189.0737 13C[M+H-(CH3)3N]+; 146.0598 [M+H-
(CH3)3N-C2H2O]+; 144.0805 [M+H-C3H9N-CO2]+; 245.1295 
[M-H]-; 246.1328 13C[M-H]-; 291.1349 [M+FA-H]-; 292.1382 
13C[M+FA-H]-; 186.0561 [M-H-(CH3)3N]-








M45 Methylcysteine C4H9NO2S 
(135.03539)
1.10 136.0425 [M+H]+ 1 (std) B > (L & P & C) S: 01h-48h 4.86x10-4
M46 Pipecolic acid C6H11NO2 
(129.07897)
1.12 130.0861 [M+H]+; 131.0894 13C[M+H]+; 152.0681 [M+Na]+ 1 (std) B > (L & P & C) S: 01h-24h 4.51x10-4
M47 Trigonelline C7H7NO2 
(137.04767)
0.88 138.0549 [M+H]+; 139.0582 13C[M+H]+; 94.0650 [M+H-CO2]+ 1 (std) B > P > L > C U: 02h-
06h
6.37x10-6
M48 y-CEHC glucose C21H30O9 
(426.18896)
6.28 444.2225 [M+NH4]+ 2 (std) (L & P & B) > C U: 06h-
12h
8.46x10-4
M49 y-CEHC glucuronide C21H28O10 
(440.16822)
6.39 441.1753 [M+H]+; 458.2016 [M+NH4]+; 459.2051 
13C[M+NH4]+; 463.1569 [M+Na]+; 501.2073 [M+H+C2H4O2]+; 
265.1434 [M+H-gluc]+; 266.1467 13C[M+H-gluc]+; 151.0752 
[M+H-gluc-H2O-C4H6-COCH2]+; 537.1381 [M-H+C2H3O2K]-
2 (std) (L & P & B) > C U: 04h-
12h
1.89x10-4







U: 381.1755 [M+H]+; 398.2020 [M+NH4]+; 379.1611 [M-H]- 
S: 379.1608 [M-H]-











U: 407.1915 [M+H]+; 424.2175 [M+NH4]+; 425.2211 
13C[M+NH4]+; 429.1737 [M+Na]+; 467.2230 [M+H+C2H4O2]+; 
389.1805 [M+H-H2O]+; 390.1839 13C[M+H-H2O]+; 231.1591 
[M+H-gluc]+; 405.1767 [M-H]-; 406.1802 13C[M-H]-; 427.1588 
[M+Na]-; 503.1539 [M-H+C2H3O2K]- 
S: 405.1765 [M-H]-
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7.07 195.1379 [M+H-gluc-H2O]+; 387.1661 [M-H]- 2 (Metlin) C > (L & P & B) U: 02h-
06h
1.43x10-2







U: 435.2222 [M+H]+; 457.2039 [M+Na]+; 417.2118 [M+H-
H2O]+; 223.1692 [M+H-gluc-2(H2O)]+; 433.2080 [M-H]-; 
434.2114 13C[M-H]-; 455.1903 [M+Na]- 
S: 433.2077 [M-H]-










5.05 261.1333 [M+H]+ 3 C > (L & P) > B U: 02h-
12h
2.38x10-2
Abbreviations: C: control; B: white beans; gluc, glucuronide; L: lentils; LI, level of identification; M, metabolite; P: chickpeas; ref, reference; RT, retention 
time; S, serum; sulf, sulfate; U, urine.
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